Patents Assigned to Mundipharma AG
  • Stabilized choline salicylate compounds
    Patent number: 4147776
    Abstract: Choline salicylate sulfite and choline salicylate alkali metal sulfite-containing compounds of the formula; ##STR1## WHEREIN Me represents the sodium, potassium, or lithium ion and R represents the sulfite, bisulfite, metabisulfite, dithionate, hydrosulfite, and hyposulfite groups are described. Said compounds are stable and inhibit the formation of color on pharmaceutical preparations containing the same. The method for the preparation of cholin-salicylate sulfite and choline salicylate alkali metal sulfite-containing compounds, and pharmaceutical dosage forms containing the same are disclosed together with a method for their use to inhibit color formation.
    Type: Grant
    Filed: February 23, 1978
    Date of Patent: April 3, 1979
    Assignee: Mundipharma, AG
    Inventors: William Kelly, deceased, John Kelly, personal representative, Alfred Halpein
  • Preparation of alkali metal choline salicylate salt complexes
    Patent number: 4098813
    Abstract: Choline salicylate sulfite and choline salicylate alkali metal sulfite-containing compounds of the formula, ##STR1## WHEREIN Me represents the sodium, potassium or lithium ion and R represents the sulfite, bisulfite, metabisulfite, dithionate, hydrosulfite and hyposulfite groups are described. Said compounds are stable and inhibit the formation of color in pharmaceutical preparations containing the same. The method for the preparation of choline salicylate sulfite and choline salicylate alkali metal sulfite-containing compounds, and pharmaceutical dosage forms containing the same are disclosed together with a method for their use to inhibit color formation.
    Type: Grant
    Filed: December 22, 1976
    Date of Patent: July 4, 1978
    Assignee: Mundipharma AG
    Inventors: William Kelly, deceased, by John Kelly, joint personal representative, Alfred Halpern